4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001628280-24-000866
Chief Financial Officer sold 16,104 shares at an average $35.27 ($567,910)
- Chief Financial Officer acquired 75,000 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Myszkowski Kenneth Allen · Chief Financial Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-01-04 | Grant or award : show line 1 in the form 10b5-1 | +75,000 | 456,704 | D | ||
| 2024-01-05 | Sale : show line 2 in the form 10b5-1 | −1,400 | $34.04 | $47,656 | 455,304 | D |
| 2024-01-05 | Sale : show line 3 in the form 10b5-1 | −5,800 | $34.97 | $202,826 | 449,504 | D |
| 2024-01-05 | Sale : show line 4 in the form 10b5-1 | −8,904 | $35.65 | $317,428 | 440,600 | D |
| Open-market sales · 16,104 sh · avg $35.27 · $567,910 | ||||||
Loading xslF345X05/wk-form4_1704752198.xml…